Literature DB >> 28202900

Cardiovascular disease prevention: lifestyle attenuation of genetic risk.

Benoit J Arsenault1, Jean-Pierre Després1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28202900     DOI: 10.1038/nrcardio.2017.20

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial.

Authors:  Stephen J Nicholls; Rishi Puri; Todd Anderson; Christie M Ballantyne; Leslie Cho; John J P Kastelein; Wolfgang Koenig; Ransi Somaratne; Helina Kassahun; Jingyuan Yang; Scott M Wasserman; Robert Scott; Imre Ungi; Jakub Podolec; Antonius Oude Ophuis; Jan H Cornel; Marilyn Borgman; Danielle M Brennan; Steven E Nissen
Journal:  JAMA       Date:  2016-12-13       Impact factor: 56.272

2.  Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.

Authors:  Rena R Wing; Paula Bolin; Frederick L Brancati; George A Bray; Jeanne M Clark; Mace Coday; Richard S Crow; Jeffrey M Curtis; Caitlin M Egan; Mark A Espeland; Mary Evans; John P Foreyt; Siran Ghazarian; Edward W Gregg; Barbara Harrison; Helen P Hazuda; James O Hill; Edward S Horton; Van S Hubbard; John M Jakicic; Robert W Jeffery; Karen C Johnson; Steven E Kahn; Abbas E Kitabchi; William C Knowler; Cora E Lewis; Barbara J Maschak-Carey; Maria G Montez; Anne Murillo; David M Nathan; Jennifer Patricio; Anne Peters; Xavier Pi-Sunyer; Henry Pownall; David Reboussin; Judith G Regensteiner; Amy D Rickman; Donna H Ryan; Monika Safford; Thomas A Wadden; Lynne E Wagenknecht; Delia S West; David F Williamson; Susan Z Yanovski
Journal:  N Engl J Med       Date:  2013-06-24       Impact factor: 91.245

3.  Normalization of visceral adiposity is required to normalize plasma apolipoprotein B levels in response to a healthy eating/physical activity lifestyle modification program in viscerally obese men.

Authors:  Emilie Pelletier-Beaumont; Benoit J Arsenault; Natalie Alméras; Jean Bergeron; Angelo Tremblay; Paul Poirier; Jean-Pierre Després
Journal:  Atherosclerosis       Date:  2012-01-20       Impact factor: 5.162

4.  Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial.

Authors:  Hui-Jie Zhang; Jiang He; Ling-Ling Pan; Zhi-Min Ma; Cheng-Kun Han; Chung-Shiuan Chen; Zheng Chen; Hai-Wei Han; Shi Chen; Qian Sun; Jun-Feng Zhang; Zhi-Bin Li; Shu-Yu Yang; Xue-Jun Li; Xiao-Ying Li
Journal:  JAMA Intern Med       Date:  2016-08-01       Impact factor: 21.873

5.  Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease.

Authors:  Amit V Khera; Connor A Emdin; Isabel Drake; Pradeep Natarajan; Alexander G Bick; Nancy R Cook; Daniel I Chasman; Usman Baber; Roxana Mehran; Daniel J Rader; Valentin Fuster; Eric Boerwinkle; Olle Melander; Marju Orho-Melander; Paul M Ridker; Sekar Kathiresan
Journal:  N Engl J Med       Date:  2016-11-13       Impact factor: 91.245

6.  Genetic variants associated with Lp(a) lipoprotein level and coronary disease.

Authors:  Robert Clarke; John F Peden; Jemma C Hopewell; Theodosios Kyriakou; Anuj Goel; Simon C Heath; Sarah Parish; Simona Barlera; Maria Grazia Franzosi; Stephan Rust; Derrick Bennett; Angela Silveira; Anders Malarstig; Fiona R Green; Mark Lathrop; Bruna Gigante; Karin Leander; Ulf de Faire; Udo Seedorf; Anders Hamsten; Rory Collins; Hugh Watkins; Martin Farrall
Journal:  N Engl J Med       Date:  2009-12-24       Impact factor: 91.245

7.  Lipoprotein(a) as a cardiovascular risk factor: current status.

Authors:  Børge G Nordestgaard; M John Chapman; Kausik Ray; Jan Borén; Felicita Andreotti; Gerald F Watts; Henry Ginsberg; Pierre Amarenco; Alberico Catapano; Olivier S Descamps; Edward Fisher; Petri T Kovanen; Jan Albert Kuivenhoven; Philippe Lesnik; Luis Masana; Zeljko Reiner; Marja-Riitta Taskinen; Lale Tokgözoglu; Anne Tybjærg-Hansen
Journal:  Eur Heart J       Date:  2010-10-21       Impact factor: 29.983

8.  Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study.

Authors:  Nicolas Perrot; Rutger Verbeek; Manjinder Sandhu; S Matthijs Boekholdt; G Kees Hovingh; Nicholas J Wareham; Kay-Tee Khaw; Benoit J Arsenault
Journal:  Atherosclerosis       Date:  2016-11-11       Impact factor: 5.162

9.  Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case-control cohort.

Authors:  Benoit J Arsenault; S Matthijs Boekholdt; Marie-Pierre Dubé; Eric Rhéaume; Nicholas J Wareham; Kay-Tee Khaw; Manjinder S Sandhu; Jean-Claude Tardif
Journal:  Circ Cardiovasc Genet       Date:  2014-04-05

10.  Genetic associations with valvular calcification and aortic stenosis.

Authors:  George Thanassoulis; Catherine Y Campbell; David S Owens; J Gustav Smith; Albert V Smith; Gina M Peloso; Kathleen F Kerr; Sonali Pechlivanis; Matthew J Budoff; Tamara B Harris; Rajeev Malhotra; Kevin D O'Brien; Pia R Kamstrup; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Matthew A Allison; Thor Aspelund; Michael H Criqui; Susan R Heckbert; Shih-Jen Hwang; Yongmei Liu; Marketa Sjogren; Jesper van der Pals; Hagen Kälsch; Thomas W Mühleisen; Markus M Nöthen; L Adrienne Cupples; Muriel Caslake; Emanuele Di Angelantonio; John Danesh; Jerome I Rotter; Sigurdur Sigurdsson; Quenna Wong; Raimund Erbel; Sekar Kathiresan; Olle Melander; Vilmundur Gudnason; Christopher J O'Donnell; Wendy S Post
Journal:  N Engl J Med       Date:  2013-02-07       Impact factor: 91.245

  10 in total
  3 in total

Review 1.  Modifiable Cardiovascular Risk, Hematopoiesis, and Innate Immunity.

Authors:  Maximilian J Schloss; Filip K Swirski; Matthias Nahrendorf
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

Review 2.  Neuroimmune axis of cardiovascular control: mechanisms and therapeutic implications.

Authors:  Daniela Carnevale
Journal:  Nat Rev Cardiol       Date:  2022-03-17       Impact factor: 32.419

Review 3.  From Diabetes Care to Diabetes Cure-The Integration of Systems Biology, eHealth, and Behavioral Change.

Authors:  Ben van Ommen; Suzan Wopereis; Pepijn van Empelen; Hilde M van Keulen; Wilma Otten; Marise Kasteleyn; Johanna J W Molema; Iris M de Hoogh; Niels H Chavannes; Mattijs E Numans; Andrea W M Evers; Hanno Pijl
Journal:  Front Endocrinol (Lausanne)       Date:  2018-01-22       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.